NCT04251455

Brief Summary

Temporomandibular joint (TMJ) diseases or dysfunctions affects many patients. Surgical treatment is planned when non-invasive interventions have failed. Still, much is not known regarding aetiology of TMJ diseases and how and why the disease develops over time. The study aims to investigate synovial tissue, synovial fluid and clinical characteristics for patients with TMJ diseases or dysfunctions designated for surgery. Patient samples and clinical variables will be analysed in relation to TMJ diagnosis and related to surgical outcome. The study is a cohort observational study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 14, 2014

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

January 28, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
Last Updated

February 5, 2020

Status Verified

January 1, 2020

Enrollment Period

4.4 years

First QC Date

January 28, 2020

Last Update Submit

January 30, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Characterisation of synovial tissue

    Synovial tissue, harvested during surgery, will be assessed through: common histo-pathology analysis, immunohistochemistry, protein analysis in immunoassays, cell characterisation with flow cytometry, and gene expression profiles with PCR.

    1-5 years after study completion

  • Characterisation of synovial fluid

    Synovial fluid, harvested during surgery, will be assessed through: immunoassays, masspectrometry.

    1-5 years after study completion

Secondary Outcomes (4)

  • Comparison of protein content

    1-5 years after study completion

  • Outcome of surgery, change in four different variables

    Pre-surgery,6 months after surgery

  • Factors predicting surgery

    Pre-surgery, during surgery

  • General joint hypermobility

    Pre-surgery.

Study Arms (1)

TMJ disease/disorder characterisation

Patients with the diagnosis disc displacement without reduction (DDwoR), or disc displacement with reduction (DDwR), or osteoarthritis (OA), or chronic inflammatory arthritis (CIA) were designated to TMJ surgery. According to the Swedish national guidelines on TMJ surgery DDwoR, OA, and CIA patients had arthroscopy and DDwR had discectomy.

Procedure: Arthroscopy or discectomy with sampling of synovial fluid and synovial tissue

Interventions

Arthroscopic lysis and lavage: performed under general anaesthesia. Before initiation of arthroscopy synovial fluid was sampled with a push-and-pull method. The TMJ was investigated with an arthroscope during irrigation with sterile saline solution. Adhesions were addressed with a coblator. Synovial tissue biopsies were taken from the posterior attachment of the disc. Discectomy without replacement: performed under general anaesthesia. Before initiation of surgery, synovial fluid was sampled as above described. During surgery synovial tissue biopsies were taken as described above.

TMJ disease/disorder characterisation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred to the department of Craniofacial Diseases, Karolinska University Hospital, Stockholm, Sweden, because of disc displacement with reduction (DDwR), disc displacement without reduction (DDwoR), osteoarthritis, and chronic inflammatory arthritis (CIA) were eligible for inclusion. Written informed consent were mandatory. Diagnoses were set according to the Diagnostic Criteria for Temporomandibular Disorders accept CIA, where a rheumatologist had to set the diagnosis. Apart from above mentioned diagnoses criteria for surgery were: visual analogue scale (VAS) value of ≥ 4 for TMJ pain or TMJ disability, and DDwoR patients had to have a maximal interincisal opening (MIO) of ≤ 35 mm.

You may qualify if:

  • Age 18 or older
  • diagnosis DDwoR, DDwR, OA, or CIA
  • conservative treatment (i.e. orthotic split, physiotherapy, medication) tried for at least 3-6 months without success

You may not qualify if:

  • earlier TMJ surgery
  • age under 18 years
  • patients not able to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet, Department of Dental Medicine

Huddinge, 14104, Sweden

Location

Biospecimen

Retention: SAMPLES WITH DNA

Synovial tissue: biopsies taken from the superior aspect of the posterior band of the TMJ disc attachment. Synovial fluid: synovial fluid samples will be taken with the push-and-pull method.

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Interventions

ArthroscopyDiskectomy

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeOrthopedic ProceduresTherapeuticsDecompression, Surgical

Study Officials

  • Bodil Lund, Professor

    Karolinska Institutet, University of Bergen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 28, 2020

First Posted

February 5, 2020

Study Start

January 14, 2014

Primary Completion

June 5, 2018

Study Completion

June 5, 2018

Last Updated

February 5, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations